Tomorrow Cardiovascular Limited

POWER SEARCH PRICING

SOLUTIONS

tomorrow cardiovascular limited Company Information

Company Number

03773485

Next Accounts

Jan 2026

Directors

Charles McCollum

Richard Pole

View All

Shareholders

charles n. mccollum

richard simon pole

View All

Group Structure

View All

Industry

Hospital activities

Registered Address

c/o wyatt morris golland ltd, park house, rochdale, OL16 1PJ

Website

http://ivs-online.co.uk

tomorrow cardiovascular limited Estimated Valuation

£4.4m

Pomanda estimates the enterprise value of TOMORROW CARDIOVASCULAR LIMITED at £4.4m based on Net Assets of £1.7m and 2.53x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Tomorrow Cardiovascular Limited is a live company located in rochdale, OL16 1PJ with a Companies House number of 03773485. It operates in the hospital activities sector, SIC Code 86101. Founded in May 1999, it's largest shareholder is charles n. mccollum with a 41.1% stake. Tomorrow Cardiovascular Limited is a mature, small sized company, Pomanda has estimated its turnover at £4.7m with high growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded Tomorrow Cardiovascular Limited a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 3 areas for improvement. Company Health Check FAQs

Health Rating4.5out of 5

4 Strong

5 Regular

3 Weak

Size

annual sales of £4.7m, make it in line with the average company (£4.1m)

Growth

3 year (CAGR) sales growth of 23%, show it is growing at a faster rate (9.2%)

EXPORT

Tomorrow Cardiovascular Limited's latest turnover from April 2024 is estimated at £4.7 million and the company has net assets of £1.7 million. According to their latest financial statements, Tomorrow Cardiovascular Limited has 52 employees and maintains cash reserves of £498.1 thousand as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Apr 2024	Apr 2023	Apr 2022	Apr 2021	Apr 2020	Apr 2019	Apr 2018	Apr 2017	Apr 2016	Apr 2015	Apr 2014	Apr 2013	Apr 2012	Apr 2011	Apr 2010
Turnover	4,723,462	3,649,196	4,382,648	2,515,996	3,263,070	4,556,133	3,196,384	2,939,389	2,029,131	6,174,466	5,312,951	3,546,495	4,214,736	6,702,461	13,046,678
Other Income Or Grants
Cost Of Sales	3,034,727	2,333,072	2,711,150	1,573,068	2,202,540	3,084,992	2,094,849	1,809,600	1,246,487	3,894,536	3,207,272	2,244,976	2,746,896	4,323,731	9,621,275
Gross Profit	1,688,735	1,316,124	1,671,499	942,928	1,060,530	1,471,141	1,101,535	1,129,789	782,644	2,279,930	2,105,679	1,301,519	1,467,840	2,378,730	3,425,403
Admin Expenses	1,490,582	2,190,886	1,845,669	519,423	1,088,733	1,041,389	887,539	855,518	1,077,601	2,266,985	2,073,964	1,048,827	1,362,031	2,031,869	2,809,689
Operating Profit	198,153	-874,762	-174,170	423,505	-28,203	429,752	213,996	274,271	-294,957	12,945	31,715	252,692	105,809	346,861	615,714
Interest Payable
Interest Receivable	19,731	29,513	9,242	1,230	737	3,776	2,441	616	776	819	1,976	2,789	2,123	1,413	597
Pre-Tax Profit	217,884	-845,249	-164,928	424,735	-27,466	433,527	216,437	274,886	-294,181	13,764	33,691	255,481	107,932	348,274	616,311
Tax	-54,471			-80,700		-82,370	-41,123	-52,228		-2,753	-7,075	-58,761	-25,904	-90,551	-172,567
Profit After Tax	163,413	-845,249	-164,928	344,035	-27,466	351,157	175,314	222,658	-294,181	11,011	26,616	196,720	82,028	257,723	443,744
Dividends Paid
Retained Profit	163,413	-845,249	-164,928	344,035	-27,466	351,157	175,314	222,658	-294,181	11,011	26,616	196,720	82,028	257,723	443,744
Employee Costs	1,811,005	1,306,183	1,396,412	1,456,394	1,529,433	1,488,297	1,368,902	1,464,103	1,507,215	2,863,701	2,196,045	1,605,272	1,719,314	2,650,678	5,140,319
Number Of Employees	52	41	47	52	56	53	49	53	55	106	80	60	65	101	198
EBITDA*	311,344	-766,875	-13,893	598,811	191,939	612,937	422,076	459,491	-294,957	184,275	224,321	388,456	244,697	473,552	721,933

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Apr 2024	Apr 2023	Apr 2022	Apr 2021	Apr 2020	Apr 2019	Apr 2018	Apr 2017	Apr 2016	Apr 2015	Apr 2014	Apr 2013	Apr 2012	Apr 2011	Apr 2010
Tangible Assets	559,221	149,127	230,217	342,512	479,984	448,822	450,449	577,081	478,389	612,678	442,740	466,300	354,003	279,647	265,128
Intangible Assets	38,622
Investments & Other	1,166,641	657,972	423,019	418,420	197,386	233,920	233,920	183,239	52,270	92,170		53,477
Debtors (Due After 1 year)						57,361	55,123	52,885	44,750
Total Fixed Assets	1,764,484	807,099	653,236	760,932	677,370	740,103	739,492	813,205	575,409	704,848	442,740	519,777	354,003	279,647	265,128
Stock & work in progress	23,324	10,776	14,860	19,555	36,073	32,275	30,160	36,733	33,894	26,534	23,866	32,804	28,929	41,972	52,378
Trade Debtors	543,256	595,032	657,904	250,142	328,175	770,282	468,463	372,946	188,598	830,073	788,128	381,448	231,450	723,944	961,603
Group Debtors		5,189
Misc Debtors	389,808	296,761	299,049	887,217	641,359	853,018	829,931	801,876	631,995
Cash	498,053	253,604	1,135,226	1,329,370	1,130,621	342,472	664,358	312,059	180,476	129,937	197,522	592,764	522,686	326,443	238,911
misc current assets										227,082	121,707	142,454	315,672
total current assets	1,454,441	1,161,362	2,107,039	2,486,284	2,136,228	1,998,047	1,992,912	1,523,614	1,034,963	1,213,626	1,131,223	1,149,470	1,098,737	1,092,359	1,252,892
total assets	3,218,925	1,968,461	2,760,275	3,247,216	2,813,598	2,738,150	2,732,404	2,336,819	1,610,372	1,918,474	1,573,963	1,669,247	1,452,740	1,372,006	1,518,020
Bank overdraft
Bank loan
Trade Creditors	347,155	59,254	19,607	66,179	244,316	77,110	59,108	232,980	36,815	369,192	179,289	218,935	412,131	488,615	892,643
Group/Directors Accounts	355,612	275,093	323,061	285,606
other short term finances
hp & lease commitments		15,143	14,993
other current liabilities	711,969	495,827	435,873	737,003	742,281	822,089	1,034,235	674,772	499,561
total current liabilities	1,414,736	845,317	793,534	1,088,788	986,597	899,199	1,093,343	907,752	536,376	369,192	179,289	218,935	412,131	488,615	892,643
loans
hp & lease commitments
Accruals and Deferred Income										187,924	132,378	182,255
other liabilities
provisions	81,384	61,644	59,992	86,751	99,359	83,843	80,556	91,726	68,017	17,360	38,377	53,056	47,436	22,028	18,520
total long term liabilities	81,384	61,644	59,992	86,751	99,359	83,843	80,556	91,726	68,017	205,284	170,755	235,311	47,436	22,028	18,520
total liabilities	1,496,120	906,961	853,526	1,175,539	1,085,956	983,042	1,173,899	999,478	604,393	574,476	350,044	454,246	459,567	510,643	911,163
net assets	1,722,805	1,061,500	1,906,749	2,071,677	1,727,642	1,755,108	1,558,505	1,337,341	1,005,979	1,343,998	1,223,919	1,215,001	993,173	861,363	606,857
total shareholders funds	1,722,805	1,061,500	1,906,749	2,071,677	1,727,642	1,755,108	1,558,505	1,337,341	1,005,979	1,343,998	1,223,919	1,215,001	993,173	861,363	606,857

	Apr 2024	Apr 2023	Apr 2022	Apr 2021	Apr 2020	Apr 2019	Apr 2018	Apr 2017	Apr 2016	Apr 2015	Apr 2014	Apr 2013	Apr 2012	Apr 2011	Apr 2010
Operating Activities
Operating Profit	198,153	-874,762	-174,170	423,505	-28,203	429,752	213,996	274,271	-294,957	12,945	31,715	252,692	105,809	346,861	615,714
Depreciation	111,189	107,887	160,277	175,306	220,142	183,185	208,080	185,220		171,330	192,606	135,764	138,888	126,691	106,219
Amortisation	2,002
Tax	-54,471			-80,700		-82,370	-41,123	-52,228		-2,753	-7,075	-58,761	-25,904	-90,551	-172,567
Stock	12,548	-4,084	-4,695	-16,518	3,798	2,115	-6,573	2,839	7,360	2,668	-8,938	3,875	-13,043	-10,406	52,378
Debtors	36,082	-59,971	-180,406	167,825	-711,127	327,144	125,810	362,364	35,270	41,945	406,680	149,998	-492,494	-237,659	961,603
Creditors	287,901	39,647	-46,572	-178,137	167,206	18,002	-173,872	196,165	-332,377	189,903	-39,646	-193,196	-76,484	-404,028	892,643
Accruals and Deferred Income	216,142	59,954	-301,130	-5,278	-79,808	-212,146	359,463	175,211	311,637	55,546	-49,877	182,255
Deferred Taxes & Provisions	19,740	1,652	-26,759	-12,608	15,516	3,287	-11,170	23,709	50,657	-21,017	-14,679	5,620	25,408	3,508	18,520
Cash flow from operations	732,026	-601,567	-203,253	170,781	1,002,182	10,451	436,137	437,145	-307,670	361,341	-284,698	170,501	673,254	230,546	446,548
Investing Activities
capital expenditure	-561,907	-26,797	-47,982	-37,834	-251,304	-181,558	-81,448	-283,912	134,289	-341,268	-169,046	-248,061	-213,244	-141,210	-371,347
Change in Investments	508,669	234,953	4,599	221,034	-36,534		50,681	130,969	-39,900	92,170	-53,477	53,477
cash flow from investments	-1,070,576	-261,750	-52,581	-258,868	-214,770	-181,558	-132,129	-414,881	174,189	-433,438	-115,569	-301,538	-213,244	-141,210	-371,347
Financing Activities
Bank loans
Group/Directors Accounts	80,519	-47,968	37,455	285,606
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments	-15,143	150	14,993
other long term liabilities
share issue	497,892					-154,554	45,850	108,704	-43,838	109,068	-17,698	25,108	49,782	-3,217	163,113
interest	19,731	29,513	9,242	1,230	737	3,776	2,441	616	776	819	1,976	2,789	2,123	1,413	597
cash flow from financing	582,999	-18,305	61,690	286,836	737	-150,778	48,291	109,320	-43,062	109,887	-15,722	27,897	51,905	-1,804	163,710
cash and cash equivalents
cash	244,449	-881,622	-194,144	198,749	788,149	-321,886	352,299	131,583	50,539	-67,585	-395,242	70,078	196,243	87,532	238,911
overdraft
change in cash	244,449	-881,622	-194,144	198,749	788,149	-321,886	352,299	131,583	50,539	-67,585	-395,242	70,078	196,243	87,532	238,911

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for tomorrow cardiovascular limited. Get real-time insights into tomorrow cardiovascular limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for tomorrow cardiovascular limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other small companies, companies in OL16 area or any other competitors across 12 key performance metrics.

TOMORROW CARDIOVASCULAR LIMITED group structure

Tomorrow Cardiovascular Limited has no subsidiary companies.

Ultimate parent company

TOMORROW CARDIOVASCULAR LIMITED

03773485

TOMORROW CARDIOVASCULAR LIMITED Shareholders

charles n. mccollum	41.07%
richard simon pole	27.7%
independent vascular services limited employee share trustmployee share trust	11.94%
adam antoni iftikhar-ul haque	5.95%
martin robinson	4.28%
andrew picton	3.86%
stephen grimoldby	3.47%
david willis	0.87%
mundell robinson projects limited	0.86%

Tomorrow Cardiovascular Limited currently has 5 directors. The longest serving directors include Professor Charles McCollum (May 1999) and Mr Richard Pole (Dec 2010).

officer	country	age	start	end	role
Professor Charles McCollum	England	74 years	May 1999	-	Director
Mr Richard Pole	England	52 years	Dec 2010	-	Director
Mr Adam Haque	England	38 years	Jul 2023	-	Director
Mr Martin Robinson	England	66 years	Jul 2023	-	Director
Mr David Willis	England	41 years	Jul 2023	-	Director

P&L

April 2024

turnover

4.7m

+29%

operating profit

198.2k

gross margin

35.8%

-0.87%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

April 2024

net assets

1.7m

+0.62%

total assets

3.2m

+0.64%

cash

498.1k

+0.96%

net assets

Total assets minus all liabilities

Similar Companies

michael s hennessy limited

willowbrook hospice

4.5

east cheshire hospice

hti st. james's ltd

3.5

nottingham university hospitals charity

company number

03773485

Type

Private limited with Share Capital

industry

86101 - Hospital activities

incorporation date

May 1999

ultimate parent company

None

previous names

independent vascular services limited (March 2024)

address

c/o wyatt morris golland ltd, park house, rochdale, OL16 1PJ

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 1 charges/mortgages relating to tomorrow cardiovascular limited. Currently there are 1 open charges and 0 have been satisfied in the past.

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for TOMORROW CARDIOVASCULAR LIMITED. This can take several minutes, an email will notify you when this has completed.

tomorrow cardiovascular limited Company Information

tomorrow cardiovascular limited Estimated Valuation

tomorrow cardiovascular limited Estimated Valuation

tomorrow cardiovascular limited Estimated Valuation

Tomorrow Cardiovascular Limited Overview

Tomorrow Cardiovascular Limited Health Check

TOMORROW CARDIOVASCULAR LIMITED financials

tomorrow cardiovascular limited Credit Report and Business Information

Tomorrow Cardiovascular Limited Competitor Analysis

tomorrow cardiovascular limited Ownership

tomorrow cardiovascular limited directors

tomorrow cardiovascular limited company details

tomorrow cardiovascular limited Charges & Mortgages

tomorrow cardiovascular limited Capital Raised & Share Issues BETA

tomorrow cardiovascular limited Companies House Filings - See Documents